Turn Therapeutics Inc. 8-K

What Happened
Turn Therapeutics Inc. (TTRX) filed a Current Report on Form 8-K on June 3, 2026 (Item 7.01) to disclose that it released an updated investor presentation on June 1, 2026. The company furnished the Investor Presentation as Exhibit 99.1 to the 8-K, and the filing also includes the required interactive cover page data (Exhibit 104). This disclosure was made under Regulation FD.

Key Details

• Filing date: June 3, 2026; Investor Presentation release date: June 1, 2026.
• Item reported: 7.01 (Regulation FD Disclosure); Exhibit furnished: 99.1 (Investor Presentation).
• Interactive XBRL cover page included as Exhibit 104.
• Filing does not report earnings, executive changes, mergers, or other Item-specific disclosures beyond the investor presentation.

Why It Matters
Furnishing an updated investor presentation provides investors and the market with the company’s most recent corporate and program information in a broadly accessible way. Retail investors should review Exhibit 99.1 (the presentation) for any updated details on Turn’s pipeline, strategy, timelines, or financial context; the 8-K itself confirms the presentation was furnished under Regulation FD but does not alter previously announced financial results or executive arrangements.